| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |